N. Shafqat

1.6k total citations · 1 hit paper
25 papers, 1.2k citations indexed

About

N. Shafqat is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Materials Chemistry. According to data from OpenAlex, N. Shafqat has authored 25 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Materials Chemistry. Recurrent topics in N. Shafqat's work include Enzyme Structure and Function (6 papers), Hormonal Regulation and Hypertension (6 papers) and Aldose Reductase and Taurine (4 papers). N. Shafqat is often cited by papers focused on Enzyme Structure and Function (6 papers), Hormonal Regulation and Hypertension (6 papers) and Aldose Reductase and Taurine (4 papers). N. Shafqat collaborates with scholars based in United Kingdom, Brunei and Sweden. N. Shafqat's co-authors include Udo Oppermann, Hans Jörnvall, Jawed Shafqat, Charlotta Filling, Xiaoqiu Wu, Erik Nordling, Malin Hult, Bengt Persson, Yvonne Kallberg and Monica Lindh and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Journal of Molecular Biology.

In The Last Decade

N. Shafqat

25 papers receiving 1.2k citations

Hit Papers

Short-chain dehydrogenases/reductases (SDR): the 2002 update 2003 2026 2010 2018 2003 100 200 300 400 500

Peers

N. Shafqat
N. Shafqat
Citations per year, relative to N. Shafqat N. Shafqat (= 1×) peers Erik Nordling

Countries citing papers authored by N. Shafqat

Since Specialization
Citations

This map shows the geographic impact of N. Shafqat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Shafqat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Shafqat more than expected).

Fields of papers citing papers by N. Shafqat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Shafqat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Shafqat. The network helps show where N. Shafqat may publish in the future.

Co-authorship network of co-authors of N. Shafqat

This figure shows the co-authorship network connecting the top 25 collaborators of N. Shafqat. A scholar is included among the top collaborators of N. Shafqat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Shafqat. N. Shafqat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shafqat, N., et al.. (2024). Protein expression, crystallization and in-silico studies on cytochrome P450 Oxidoreductase wildtype and mutant variants. Journal of Research in Pharmacy. 28(2)(28(2)). 560–570. 1 indexed citations
2.
Goh, Hui Poh, Inayat Ur Rehman, N. Shafqat, et al.. (2023). Assessing consumers’ perception and demand on the community pharmacists’ dispensing. Journal of Pharmaceutical Policy and Practice. 16(1). 162–162. 3 indexed citations
3.
Hermansyah, Andi, et al.. (2023). Drug-related problems in hospitalized patients with type 2 diabetes mellitus: A systematic review. SHILAP Revista de lepidopterología. 12. 100348–100348. 4 indexed citations
4.
Ming, Long Chiau, Jagjit Singh Dhaliwal, Madhu Gupta, et al.. (2022). Role of Immunotherapy in the Treatment of Cancer: A Systematic Review. Cancers. 14(21). 5205–5205. 41 indexed citations
5.
Ming, Long Chiau, et al.. (2022). In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase. Molecules. 27(14). 4646–4646. 3 indexed citations
6.
Oerum, Stephanie, James E. Bray, K.L. Kavanagh, et al.. (2014). Towards a systematic analysis of human short-chain dehydrogenases/reductases (SDR): Ligand identification and structure–activity relationships. Chemico-Biological Interactions. 234. 114–125. 27 indexed citations
7.
8.
Shafqat, N., J.R.C. Muniz, Ewa S. Pilka, et al.. (2013). Insight into S-adenosylmethionine biosynthesis from the crystal structures of the human methionine adenosyltransferase catalytic and regulatory subunits. Biochemical Journal. 452(1). 27–36. 51 indexed citations
9.
Abbasi, F, Alia Gul, Majid Azizi, et al.. (2010). Localizing introgression on the chromosome of rice by genomic in situ hybridization (GISH). AFRICAN JOURNAL OF BIOTECHNOLOGY. 9(30). 4651–4654. 2 indexed citations
10.
Shafqat, N., A.P. Turnbull, Johannes Zschocke, Udo Oppermann, & Wyatt W. Yue. (2010). Crystal Structures of Human HMG-CoA Synthase Isoforms Provide Insights into Inherited Ketogenesis Disorders and Inhibitor Design. Journal of Molecular Biology. 398(4). 497–506. 57 indexed citations
11.
Porté, Sergio, Agrin Moeini, N. Shafqat, et al.. (2010). Kinetic and structural evidence of the alkenal/one reductase specificity of human ζ-crystallin. Cellular and Molecular Life Sciences. 68(6). 1065–1077. 15 indexed citations
12.
Porté, Sergio, Emma Borràs, N. Shafqat, et al.. (2009). Three-dimensional Structure and Enzymatic Function of Proapoptotic Human p53-inducible Quinone Oxidoreductase PIG3. Journal of Biological Chemistry. 284(25). 17194–17205. 54 indexed citations
13.
Simeonov, Anton, Adam Yasgar, Wei Zheng, et al.. (2007). Evaluation of Micro-Parallel Liquid Chromatography as a Method for HTS-Coupled Actives Verification. Assay and Drug Development Technologies. 5(6). 815–824. 4 indexed citations
14.
Hult, Malin, N. Shafqat, Björn Elleby, et al.. (2006). Active site variability of type 1 11β-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons. Molecular and Cellular Endocrinology. 248(1-2). 26–33. 33 indexed citations
15.
Shafqat, N., Jawed Shafqat, Guenther Eissner, et al.. (2006). Hep27, a member of the short-chain dehydrogenase/reductase family, is an NADPH-dependent dicarbonyl reductase expressed in vascular endothelial tissue. Cellular and Molecular Life Sciences. 63(10). 1205–1213. 40 indexed citations
16.
Oppermann, Udo, K.L. Kavanagh, Petra Lukacik, et al.. (2006). SDR goes SGC: A structural genomics initiative. Oxford University Research Archive (ORA) (University of Oxford). 12. 235–241. 1 indexed citations
17.
Hult, G. Tomas M., Björn Elleby, N. Shafqat, et al.. (2004). Human and rodent type 1 11�-hydroxysteroid dehydrogenases are 7�-hydroxycholesterol dehydrogenases involved in oxysterol metabolism. Cellular and Molecular Life Sciences. 61(7-8). 992–999. 65 indexed citations
18.
Oppermann, Udo, Charlotta Filling, Malin Hult, et al.. (2003). Short-chain dehydrogenases/reductases (SDR): the 2002 update. Chemico-Biological Interactions. 143-144. 247–253. 552 indexed citations breakdown →
19.
Shafqat, N., Björn Elleby, Stefan Svensson, et al.. (2003). Comparative Enzymology of 11β-Hydroxysteroid Dehydrogenase Type 1 from Glucocorticoid Resistant (Guinea Pig) Versus Sensitive (Human) Species. Journal of Biological Chemistry. 278(3). 2030–2035. 26 indexed citations
20.
Filling, Charlotta, Xiaoqiu Wu, N. Shafqat, et al.. (2001). Subcellular targeting analysis of SDR-type hydroxysteroid dehydrogenases. Molecular and Cellular Endocrinology. 171(1-2). 99–101. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026